The SARS-CoV-2 coronavirus contains 4 major structural proteins, Spike (S), Nucleocapsid (N), Membrane (M), and Envelope (E). S, M, and E proteins form the viral coat, and the N protein packages the RNA genome. The Spike protein includes three subunits, S1, S2 and the receptor binding domain (RBD). The virus‘ RBD binds to ACE2 receptors of human cells.
Performing IgM, IgG, and IgA blood-based serology testing may help identify people who have been exposed to SARS-CoV-2, and who have generated some level of immune response. By testing the response of each immunoglobulin type against specific antigenic regions of the SARS-CoV-2 virus, researchers may further understand the immune response to the virus over the course of infection and recovery from COVID-19.
Here we introduce three separate assays, one for each immunoglobulin type, IgM, IgG and IgA.
SARS-CoV-2 Antigen Panel 1 IgM
SARS-CoV-2 Antigen Panel 1 IgG
SARS-CoV-2 Antigen Panel 1 IgA
Each assay detects one immunoglobulin type (IgM, IgG, or IgA) antibodies to 4 specific SARS-CoV-2 antigens in human serum/plasma samples.
The relative levels of detection are presented as MFI values.
4-plex panel allows to select any or all the following viral antigens:
We provide over 120 Luminex panels ready to go contact firstname.lastname@example.org for the full list
How it works
Contact email@example.com and tell your needs
Discuss our proposal and define the final panel
SOW generation and approval in order to meet your expectations
Prepare the assay layout, with or without the Labospace’s support team, and provide the data in the template provided.
The Labospace team will organize the data pick up and prepare the documentation for your laboratory.-